Trying to be the change I want to see in the Pharma industry
- The cost of insulin more than tripled — from $231 to $736 a year per patient — between 2002 and 2013.
- A new marijuana-based epilepsy treatment is going to cost $32,500 a year.
- “The goal is to keep the price of the drug on par with other epilepsy medications”.
- PBM’s are driving hard bargains with the manufacturer and they are increasingly finding ways to expand their profitability at the expense of employers and patients.